152.16 USD
+0.58 (+0.38%)
152.16 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 85% to NBIX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 177.35. This target is 16.55% above the current price.
NBIX was analyzed by 35 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about NBIX.
In the previous month the buy percentage consensus was at a similar level.
NBIX was analyzed by 35 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-03 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-30 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-10-29 | Needham | Maintains | Buy -> Buy |
| 2025-10-29 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-29 | Stifel | Maintains | Buy -> Buy |
| 2025-10-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-29 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-29 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-21 | Citigroup | Initiate | Buy |
| 2025-10-20 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-09 | UBS | Maintains | Buy -> Buy |
| 2025-09-22 | Needham | Maintains | Buy -> Buy |
| 2025-09-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-09-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-01 | Guggenheim | Maintains | Buy -> Buy |
| 2025-07-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-31 | Stifel | Maintains | Buy -> Buy |
| 2025-07-31 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-07-31 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-07-31 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-07-31 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-22 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-07-21 | Truist Securities | Initiate | Buy |
| 2025-07-10 | Goldman Sachs | Initiate | Buy |
| 2025-07-09 | UBS | Maintains | Buy -> Buy |
| 2025-06-02 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-05-06 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-06 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-05-06 | UBS | Maintains | Buy -> Buy |
NEUROCRINE BIOSCIENCES INC / NBIX FAQ
Can you provide the average price target for NEUROCRINE BIOSCIENCES INC stock?
35 analysts have analysed NBIX and the average price target is 177.35 USD. This implies a price increase of 16.55% is expected in the next year compared to the current price of 152.16.
What is the consensus rating for NEUROCRINE BIOSCIENCES INC (NBIX) stock?
The consensus rating for NEUROCRINE BIOSCIENCES INC (NBIX) is 84.5714 / 100 . This indicates that analysts generally have a positive outlook on the stock.